What does an elevated serum free light chain indicate?

What Does Elevated Serum Free Light Chain Mean?

Elevated serum free light chains (FLC) indicate either a monoclonal plasma cell disorder (when the κ/λ ratio is abnormal) or a polyclonal immune response/renal impairment (when both chains are elevated proportionally). The interpretation depends critically on whether the elevation is monoclonal or polyclonal, and whether renal function is impaired 1.

Understanding the Free Light Chain Assay

The serum FLC assay measures unbound κ and λ light chains independently and calculates the κ/λ ratio 1. This test is essential for:

• Detecting clonality: An abnormal κ/λ ratio indicates monoclonal disease
  • High ratio (>1.65) = κ clone
  • Low ratio (<0.26) = λ clone 1
• Screening for plasma cell disorders with high sensitivity when combined with serum protein electrophoresis and immunofixation 2, 3, 4
• Monitoring disease in light chain amyloidosis and oligosecretory myeloma 2, 3, 4

Critical Interpretation Based on Pattern

Monoclonal Elevation (Abnormal κ/λ Ratio)

This pattern suggests a clonal plasma cell disorder and requires immediate hematologic evaluation. The differential includes:

• Multiple myeloma (most common when symptomatic)
• Monoclonal gammopathy of undetermined significance (MGUS) 5, 6
• Light chain amyloidosis 1
• Monoclonal gammopathy of renal significance (MGRS) 1
• Waldenström macroglobulinemia or other B-cell lymphoproliferative disorders 7

Polyclonal Elevation (Normal κ/λ Ratio, Both Chains Elevated)

This pattern most commonly indicates renal impairment or chronic immune stimulation, NOT malignancy 1. Causes include:

• Renal dysfunction: Free light chains are cleared by the kidney, so impaired renal function causes accumulation 1
• Chronic inflammation or immune stimulation 8
• Autoimmune conditions
• Infections

Importantly, polyclonal FLC elevation may precede development of monoclonal gammopathy by years—patients with the highest decile of polyclonal FLC have a 2.6-fold increased risk of eventually developing a monoclonal gammopathy 8.

The Renal Function Pitfall

This is the most common source of misinterpretation. The "normal" κ/λ ratio of 0.26–1.65 shifts to 0.34–3.10 in severe renal impairment (CKD stage 5 or greater), and even small declines in renal function impair FLC clearance 1.

Key clinical implications:

• Always check renal function (eGFR, creatinine) when interpreting FLC results 9
• Standard reference ranges lead to high false-positive rates in elderly patients with renal impairment 9
• Consider eGFR-stratified reference intervals to avoid unnecessary investigations 9

Assay-Specific Considerations

The specific assay used matters significantly. At least two major assays exist (FreeLite and N Latex), and they are mathematically inconvertible 1. The N Latex assay is less affected by renal impairment than the FreeLite assay 1.

Critical practice points:

• Use the same assay for serial monitoring in individual patients 1
• If the first assay is negative but clinical suspicion remains high, check with the alternative assay 1
• Different assays may require different interpretation thresholds 10

Clinical Algorithm for Interpretation

When you see elevated FLC, follow this sequence:

1. Check the κ/λ ratio first

   • Abnormal ratio → Suspect monoclonal disorder → Proceed to full plasma cell workup
   • Normal ratio → Consider polyclonal elevation

2. If ratio is normal (polyclonal pattern):

   • Check renal function (eGFR, creatinine)
   • If renal impairment present → This likely explains the elevation
   • If renal function normal → Consider inflammatory/immune conditions

3. If ratio is abnormal (monoclonal pattern):

   • Obtain serum protein electrophoresis with immunofixation 1, 2, 3, 4
   • Obtain 24-hour urine protein electrophoresis with immunofixation 1, 2, 3, 4
   • Check CBC, calcium, creatinine, albumin, β2-microglobulin 2, 3, 4
   • Perform bone marrow biopsy with cytogenetics/FISH 2, 3, 4
   • Obtain skeletal survey 2, 3, 4

4. Risk stratification for MGUS (if no end-organ damage):

   • Low risk: M-protein <1.5 g/dL, IgG type, normal FLC ratio → 2% lifetime progression risk 6
   • High risk: All three factors abnormal → 27% progression risk at 20 years 6

When FLC Elevation Indicates Urgent Disease

Elevated FLC with end-organ damage (CRAB criteria) indicates symptomatic multiple myeloma requiring immediate treatment 2, 3, 4:

• Calcium >11.5 mg/dL
• Renal insufficiency (creatinine >1.73 mmol/L)
• Anemia (hemoglobin <10 g/dL or >2 g/dL below normal)
• Bone lesions (lytic lesions, fractures)

In patients with renal insufficiency and high FLC levels, bortezomib-based regimens should be initiated immediately without dose adjustment, as these do not require renal dose modification 11.

Prognostic Value

Beyond diagnosis, FLC measurements provide prognostic information:

• Required for documenting stringent complete response in myeloma 2, 3, 4
• Abnormal FLC ratio is an independent risk factor for MGUS progression 6
• In smoldering myeloma, FLC ratio ≤0.125 or ≥8 with ≥10% bone marrow plasma cells indicates high risk of progression within 2 years 6
• Elevated polyclonal FLC predicts cardiovascular events in type 2 diabetes 12